Symbion Health (SYB) Stock Tip

Submitted by Craig Strzelecki on Thu, 11/05/2006 - 09:57.

Merrill Lynch rates the Symbion Health (SYB) stock as a Buy, Medium Risk. This rating follows Merill Lynch communications with industry sources which give the analysts the opinion that consolidation within the Australian pharmaceutical wholesaling sector is more likely. Symbion Health Ltd. is listed on the Australian Stock Exchange under stock code SYB. Check your charts.

Free Email Subscription to Share Trading

 My Share Trading Feed